The U. S. Food and Drug Administration (FDA) today approved Ciprofloxacin (Cipro) tablets as an alternative to the antibiotic tetracycline in treating urinary tract infections (UTIs). The drug is used to treat a variety of urinary tract infections (UTIs), including bladder, kidney, prostate, colon, rectal, genital, and rectal infections.
Ciprofloxacin is an antibiotic that belongs to the class of drugs called fluoroquinolones, which is used to treat a variety of bacterial infections. It is also used to treat a range of sexually transmitted diseases, including gonorrhea, syphilis, chlamydia, and human immunodeficiency virus (HIV).
The drug is available in a liquid suspension form, and the drug is usually given in tablet form with a 500 milligram dose. The drug is available in two forms:
The FDA approved the generic version of Ciprofloxacin for the treatment of UTIs in infants and children under 12 years of age. This product is a combination of two drugs: Ciprofloxacin and Tetracycline. Ciprofloxacin is used to treat certain types of bacterial infections, including urinary tract infections, including bladder, kidney, prostate, and colon infections. Tetracycline is used to treat certain types of bacterial infections, including pneumonia, bronchitis, chlamydia, gonorrhea, and syphilis.
Ciprofloxacin is an antibiotic that belongs to the class of drugs called fluoroquinolones, which is used to treat a variety of bacterial infections, including urinary tract infections, including bladder, kidney, prostate, and colon infections.
The FDA approved Ciprofloxacin for the treatment of urinary tract infections in infants and children under 12 years of age. Ciprofloxacin is available in a liquid suspension form, and the drug is usually given in tablet form with a 500 mg/4 ml dose. The drug is available in 2.5 mL and 1.5 mL strengths, taken twice a day.
Ciprofloxacin (Cipro) is an antibiotic that belongs to the class of drugs called fluoroquinolones, which is used to treat a variety of bacterial infections, including urinary tract infections, including bladder, kidney, prostate, and colon infections.Tip:Do not touch the dropper to any surface, including the surface of your pet's eye.
| Dosage for Cats, Dogs & Horses | |
|---|---|
| Weight | Dosage |
| All weights | Use as prescribed by your veterinarian. |
Safe use in pregnant pets or pets intended for breeding has not been proven. If your pet's condition worsens or does not improve, stop product administration and consult your veterinarian. Ciprofloxacin Hydrochloride Ophthalmic Solution 0.3% is for topical ophthalmic use only. It is not for injection into the eye. Sensitivity to topically applied aminoglycosides may occur in some pets. If your pet has a reaction to Ciprofloxacin Hydrochloride Ophthalmic Solution 0.3%, discontinue use and consult your veterinarian.
Store at 36°-77°F (2°-25°C).
A history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use. A history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin.
Not for Injection into the Eye.
Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolone therapy. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial edema, dyspnea, urticaria, and itching. Only a few patients had a history of hypersensitivity reactions. Serious anaphylactic reactions require immediate emergency treatment with epinephrine and other resuscitation measures, including oxygen, intravenous fluids, intravenous antihistamines, corticosteroids, pressor amines and airway management, as clinically indicated.
Remove contact lenses before using.
Contraindications caused by a history of hypersensitivity reactions to ciprofloxacin.For advice about dosage and whether or not a suitable PBM for your specific condition, speak with your veterinarian.
Some ( such as injection into the eye, eye irritation, eye pain, sensitivity to local anesthetics, allergic reactions, blepharospasm, hives, and rashes), have been observed.
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
• No dosage increase described • Conventional evidence does not support the use of this medicine in patients with renal or hepatic impairment. • Conventional evidence does not support the use of this medicine in patients with a severe liver impairment. • Conventional evidence does not support the use of this medicine in patients with severe renal impairment. • Conventional evidence does not support the use of this medicine in patients with severe hepatic impairment. • Conventional evidence does not suggest that this medicine should be taken with food. • Conventional evidence suggests that this medicine is unlikely to work if taken at the dose prescribed by your doctor. • Patients should be advised to seek medical advice immediately if they experience an infection of the biliary tract, vomiting, nausea, diarrhea, pain, fever, irregular heartbeat, muscle pain or weakness, headache or dizziness, slurred speech, dizziness or fainting when on standing. • This medicine should not be administered to pregnant women or lactating mothers. This medicine should not be used by patients who are or may potentially be pregnant or breastfeeding. • This medicine should not be used by patients who are or may potentially be breastfeeding. • This medicine should not be used by patients who are or may potentially be pregnant or breastfeeding.The Canadian Ciprofloxacin HCl (FCOH) product portfolio consists of the following products:
• Ciprofloxacin HCl is a broad-spectrum antibiotic used to treat a wide range of bacterial infections including:
• Acinetobacter species such as A. catarrhalis and A. aerogenes (both Gram-negative and Gram-positive) and the Gram-positive bacteria Streptococcus spp., Providencia spp., Staphylococcus spp., and E. coli
• Bacterial infections caused by Escherichia coli, Klebsiella spp. and Enterobacter spp., such as pneumonia, tonsillitis and ear infections
• Bacterial infections caused by other bacteria such as Proteus mirabilis, Proteus vulgaris and Neisseria gonorrhoeae
• Antibiotics such as ampicillin and tetracyclines
• Antibiotic based products available in the form of a combination of amoxicillin and ciprofloxacin
• Acyclovir (Acyclovir) or other antiviral drugs for viral or fungal infections
• Antibiotics such as ciprofloxacin and ciprofloxacin-sulfamethoxazole
• Antibiotic based products available in the form of combination of amoxicillin and ciprofloxacin
• Antimicrobial based products available in the form of combination of amoxicillin and ciprofloxacin
• Antibiotics used to treat infections caused by susceptible or resistant bacteria (e.g. pneumonia, tonsillitis and otitis, as well as bacterial skin infections, urinary tract infections, and gonorrhea)
• Antibiotics used to treat bacterial infections such as pneumonia, tonsillitis and ear infections
• Antibiotics used to treat infections caused by susceptible bacteria such as Streptococcus pneumoniae and other Gram-negative organisms (e.g. Haemophilus spp., Klebsiella pneumoniae andMoraxella catarrhalis)
• Antibiotics used to treat infections caused by susceptible bacteria such as Streptococcus pyogenes, Enterococcus faecalis and Staphylococcus spp. (e.g. streptococci, Haemophilus spp., Proteus spp., Klebsiella spp., Proteus vulgaris, Proteus spp., Klebsiella spp., Providencia spp., S. aureofaciens, and other Streptococcus spp.)
• Bacterial infections caused by susceptible or resistant organisms such as Escherichia coli, Klebsiella spp. and Enterobacter spp., such as pneumonia, tonsillitis and otitis media
• Bacterial infections caused by Gram-negative organisms such as Neisseria gonorrhoeae
• Bacterial infections caused by susceptible bacteria such as Proteus mirabilis, Proteus vulgaris and Streptococcus spp. streptococci, Proteus spp., Klebsiella pneumoniae and Moraxella catarrhalis)
• Bacterial infections caused by Gram-negative organisms such as Pseudomonas aeruginosa, Pseudomonas aeruginosa and Enterococcus faecalis
• Bacterial infections caused by Gram-negative organisms such as Proteus mirabilis, Pseudomonas aeruginosa and Streptococcus spp. streptococci, Pseudomonas aeruginosa, Proteus spp.
Drug Name
Ciprofloxacin is an antibiotic used to treat various infections caused by bacteria. Ciprofloxacin interacts with certain types of bacteria, especially those that are resistant to other antibiotics.
Drug Uses
Ciprofloxacin is prescribed to treat conditions such as:
Ciprofloxacin is also prescribed to treat bacterial skin infections, such as acne, rosacea, and rosacea caused by certain bacteria. Ciprofloxacin may also be prescribed for other infections.
Dosage
Ciprofloxacin should be taken at least 2 hours before or after meals. Ciprofloxacin can be taken with or without food. Do not take more than the prescribed dose. It is best to take the medication with food to reduce stomach upset.
Interaction
Ciprofloxacin should not be used with nitrofurantoin. Ciprofloxacin may increase the level of nitrate in blood. Ciprofloxacin may be taken with other antibiotics.
Storage
Store at room temperature away from moisture and heat. Keep out of the reach of children.
Ciprofloxacin is an antibiotic used to treat certain types of infections, including:
Ciprofloxacin may interact with nitrofurantoin. Nitrofurantoin can increase the level of nitrate in blood. Do not take Ciprofloxacin with nitrofurantoin.
Agarwal, A., Kulkarni, S., & Sathapoor, M. (2009). Drug resistance: an emerging global threat and a threat to public health. Int J Drug Reshet Metab Dis Sci.
Agarwal, A., & Sathapoor, M. (2011). Global threat of antibiotic resistance: the case of the drug Ciprofloxacin and its use in the fight against tuberculosis.
Agarwal, A., & Kulkarni, S. (2013). The development of new antibiotic drugs: a global and international review of the drugs that have been approved and used for clinical use. J Med Chem.
Global threat of drug-resistant tuberculosis: a review of clinical practice and policy in India and Pakistan.
Babu, S., & Tawani, M. (2007). A comparison of the antimicrobial resistance of carbapenems and trimethoprim-sulfamethoxazole. J Am Coll Infect Dis.
(2006).
(2012).
(2014).
(2015).
(2016).
(2017).
(2018).
Stade de France Pharmacy